Skip to main content
Binex Co., Ltd. logo

Binex Co., Ltd. — Investor Relations & Filings

Ticker · 053030 ISIN · KR7053030003 KO Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2020-03-13 Audit Report / Informat…
Country KR South Korea
Listing KO 053030

About Binex Co., Ltd.

http://www.binex.co.kr/

Binex Co., Ltd. is a biopharmaceutical company engaged in two main sectors: synthetic pharmaceuticals and biologics contract services. The pharmaceutical division manufactures and distributes a portfolio of products, including gastrointestinal tract regulators, antispasmodics, and anti-cancer drugs. As a Contract Development and Manufacturing Organization (CDMO), the company provides comprehensive services for biologics, specializing in cell line development, process development, and analytical method development. Its quality management systems are recognized by major international regulatory authorities such as the FDA, EMA, and PMDA, establishing it as a key partner in biopharmaceutical development and manufacturing.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korean financial authorities (DART system). It provides the audit opinion (which is 'unqualified' or '적정'), key financial data (assets, liabilities, revenue, profit), and details regarding the external auditor. While it contains financial data, it is a specific regulatory disclosure of the audit results rather than the full 10-K annual report itself. In the context of Korean regulatory filings, this is classified as an Audit Report/Information filing. FY 2019
2020-03-13 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Audit Report / Information Classification · 95% confidence The document is a regulatory filing from the Korean stock exchange (KIND) regarding a correction (정정신고) to a previously filed financial performance report (specifically, a change in revenue or profit/loss structure of 30% or more). It details the specific line items that were adjusted due to the external audit process. Since this is a formal regulatory disclosure of financial data updates rather than a full annual report or a simple announcement of a report's availability, it falls under the category of general regulatory filings. FY 2019
2020-03-13 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Binex. It outlines the date, location, agenda items (such as financial statement approval and director appointments), and details regarding the board's resolution. This is a standard proxy solicitation/notice document sent to shareholders to inform them of an upcoming meeting and the matters to be voted upon.
2020-03-04 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Binex Co., Ltd. It contains the meeting agenda, voting procedures, electronic voting information, and management reports (such as board activities and business overview) required for shareholders to review before the meeting. This type of document is classified as a Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on company matters.
2020-03-04 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation & Information Statement' (PSI) filed by Binex Co., Ltd. It contains details regarding the upcoming Annual General Meeting (AGM), including the date, location, purpose of the meeting, and information on the solicitation of proxy votes. It also includes financial statements (Balance Sheet, Income Statement, Cash Flow Statement) as part of the reference materials for shareholders to review before voting. Since the primary purpose of this document is to provide information and request votes for the meeting, it is classified as a Proxy Solicitation & Information Statement.
2020-03-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 95% confidence The document is a regulatory filing from a Korean company (Binex) announcing a significant change in revenue or profit structure (exceeding 15-30%). This is a standard disclosure requirement in the Korean stock market (KRX) when financial results show material variance. It provides key financial highlights (revenue, operating profit, net income) and the reasons for the change, but it is not a full annual report or an earnings release transcript. Given it is a specific regulatory disclosure of financial performance metrics, it falls under the 'Earnings Release' category as it serves as the initial announcement of financial results. FY 2019
2020-02-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.